fluoxetine has been researched along with Sleep Apnea, Obstructive in 5 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Sleep Apnea, Obstructive: A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Selective serotonin reuptake inhibitors, while instructive with regard to mechanism, require impractical dosing and may carry additional risk in the form of greater challenges for resuscitation." | 1.56 | An oxygen-rich atmosphere or systemic fluoxetine extend the time to respiratory arrest in a rat model of obstructive apnea. ( Banerjee, A; Gurevich, R; Kollmar, R; Mooney, S; Silverman, JB; Stewart, M; Sundaram, K; Tromblee, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mooney, S | 1 |
| Kollmar, R | 1 |
| Gurevich, R | 1 |
| Tromblee, J | 1 |
| Banerjee, A | 1 |
| Sundaram, K | 1 |
| Silverman, JB | 1 |
| Stewart, M | 1 |
| Applebee, GA | 1 |
| Attarian, HP | 1 |
| Schenck, CH | 1 |
| Prasad, B | 1 |
| Radulovacki, M | 1 |
| Olopade, C | 1 |
| Herdegen, JJ | 1 |
| Logan, T | 1 |
| Carley, DW | 1 |
| Smith, SS | 1 |
| Dingwall, K | 1 |
| Jorgenson, G | 1 |
| Douglas, J | 1 |
| Aylwin, S | 1 |
| Al-Zaman, Y | 1 |
1 review available for fluoxetine and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria | 2008 |
1 trial available for fluoxetine and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine | 2010 |
3 other studies available for fluoxetine and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
An oxygen-rich atmosphere or systemic fluoxetine extend the time to respiratory arrest in a rat model of obstructive apnea.
Topics: Animals; Death, Sudden; Fluoxetine; Male; Oxygen; Rats, Sprague-Dawley; Respiration; Seizures; Selec | 2020 |
An angry bed partner.
Topics: Anger; Antidepressive Agents, Second-Generation; Bupropion; Coronary Artery Disease; Depressive Diso | 2009 |
Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Antidepressive Agents; Aspirin; Drug Therapy; Female; Fl | 2006 |